Neurocognitive & Radiological Assessments in Adult Moyamoya Undergoing

Status Recruiting

Clinical Trial Summary

Adult patients with moyamoya disease (MMD) are reported to suffer from considerable impairment of executive function/attention. Although reduced cerebrovascular reserve (CVR) in frontal areas has been detected by perfusion MRI and then confirmed to be associated with executive dysfunction in adult MMD, the structural and functional changes is still unclear with progression of executive dysfunction. Furthermore, it is very important to study the association between the neurocognitive and radiological improvement after surgical revascularization, so as to help detecting cerebral regions which are involved in executive deterioration or improvement after surgery. Then the investigators can determine whether these regions can be used as indicators to decide rational therapeutic schedule and timing of adult MMD with executive dysfunction.

Thus the aim of this study is to primarily find out the neuropsychological and radiological correlates in adult MMD, and then to quantitatively evaluate the effectiveness of surgical revascularization in prevention of executive dysfunction in adult MMD.

Clinical Trial Description

Previous studies of adult moyamoya disease (MMD) have revealed that vascular cognitive impairment (VCI) is the consequence of ischemic damage to dynamic factors such as cerebral hypoperfusion, rather than to cerebral gray matter. However, it is still unclear which regions are affected by MMD and how these regions respond to the progressive cognitive decline. In other way, the investigators need to detect spatial patterns in the brain activity of MMD in order to understand its pathophysiological nature.

Surgical revascularization has been accepted as the only effective form of treatment in preventing future ischemic episodes. However, its effectiveness in cognitive protection is still unknown. Thus, the investigators determine to quantitatively evaluate cognitive and radiological outcomes in adult MMD postoperatively and during follow-ups. ;

Study Design

Related Conditions & MeSH terms

Moyamoya Disease

Clinical Trial Details

NCT number	NCT02305407
Study type	Interventional
Source	Huashan Hospital
Contact	Yu Lei, MD
Phone	+86 021 52889999
Email	piliyouxia_lei@126.com
Status	Recruiting
Phase	N/A
Start date	March 2016
Completion date	May 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03785171` - Predicative Value of Multimodal MRI in Moyamoya Disease
Recruiting	`NCT05619068` - The Evolution and Prognosis of Moyamoya Disease
Recruiting	`NCT03613701` - Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease
Recruiting	`NCT06041659` - Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
Not yet recruiting	`NCT06051552` - Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery
Suspended	`NCT04064658` - Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients	N/A
Recruiting	`NCT03627975` - Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease	N/A
Not yet recruiting	`NCT06330818` - Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients	N/A
Recruiting	`NCT05332756` - Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
Recruiting	`NCT04890782` - Gut Microbiota in Patients With Moyamoya Disease
Completed	`NCT03162588` - Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya	Phase 1/Phase 2
Completed	`NCT03072914` - Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome	N/A
Recruiting	`NCT04917003` - Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease	N/A
Completed	`NCT04012268` - The Safety and Efficacy of RIC on Adult Moyamoya Disease	N/A
Not yet recruiting	`NCT04205578` - NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events	Phase 3
Recruiting	`NCT02982135` - Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease	N/A
Recruiting	`NCT02074111` - Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke	N/A
Recruiting	`NCT04696094` - The Role of m6A RNA Modification in Moyamoya Disease
Completed	`NCT04906564` - RNF213 Variants and Collateral Vessels in Moyamoya Disease
Recruiting	`NCT05961748` - Registry of Multicenter Brain-Heart Comorbidity in China

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery — NRAAMUS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms